Molecular Variants of Soluble Guanylyl Cyclase Affecting Cardiovascular Risk-Reference-Cited by-同舟云学术

Molecular Variants of Soluble Guanylyl Cyclase Affecting Cardiovascular Risk

Published:2015 Issue:3 Volume:79 Page:463-469
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Wobst Jana¹,Rumpf Philipp Moritz¹,Dang Tan An¹,Segura-Puimedon Maria²,Erdmann Jeanette³²,Schunkert Heribert⁴¹

Affiliation:

1. Department of Cardiovascular Diseases, German Heart Center Munich, Technical University Munich

2. Institute for Integrative and Experimental Genomics, University of Lübeck

3. German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck

4. German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/79/3/79_CJ-15-0025/_pdf

Reference67 articles.

1. 1. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87–94.

2. 2. Hevel JM, White KA, Marletta MA. Purification of the inducible murine macrophage nitric oxide synthase: Identification as a flavoprotein. J Biol Chem 1991; 266: 22789–22791.

3. 3. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251–1256.

4. 4. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89: 6348–6352.

5. 5. Ursell PC, Mayes M. The majority of nitric oxide synthase in pig heart is vascular and not neural. Cardiovasc Res 1993; 27: 1920–1924.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 685509, a soluble guanylyl cyclase activator, in healthy volunteers: Results from two randomized controlled trials;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-24

2. Co-expression of soluble guanylyl cyclase subunits and PDE5A shRNA to elevate cellular cGMP level: A potential gene therapy for myocardial cell death;Technology and Health Care;2022-11-17

3. Gemfibrozil derivatives as activators of soluble guanylyl cyclase – A structure-activity study;European Journal of Medicinal Chemistry;2021-11

4. Comparative efficiency of three gasotransmitters (nitric oxide, hydrogen sulfide and carbon monoxide): Analysis on the model of red blood cell microrheological responses;Journal of Cellular Biotechnology;2021-08-06

5. The role of gaseous mediators (CO, NO and H2S) in the regulation of blood circulation: analysis of the participation of blood cell microrheology;Regional blood circulation and microcirculation;2021-03-22